Hackernews posts about BioNTech
BioNTech is a German biotechnology company that develops and commercializes immunotherapy treatments, including vaccines and cell therapies, using messenger RNA (mRNA) technology.
- BioNTech to Host Innovation Series R&D Day on November 11, 2025 (investors.biontech.de)
- China Pushes Boundaries with Animal Testing to Win Global Biotech Race (www.bloomberg.com)
- 'Biotech Barbie' says the time has come to consider CRISPR babies (www.nature.com)
- Biotech companies I wish existed (blog.eladgil.com)
- Biotech Hunter – Crunchbase for Life Sciences (biotechhunter.com)
- Biotech Galapagos winds down cell therapy, threatens 365 jobs and 5 facilities (www.fiercebiotech.com)
- Show HN: A 3D visualization of all YC startups based on their mission statements (www.startup-galaxy.com)
- Moderna has unraveled (www.statnews.com)
- Arena BioWorks, funded with $500M, folds less than 2 years after launch (www.fiercebiotech.com)
- Intellia pauses phase 3 CRISPR trials after patient is hospitalized (www.fiercebiotech.com)
- BridgeBio aces phase 3 rare disease test, clearing path to FDA (www.fiercebiotech.com)
- Takeda turns to AI drug designer after whittling down R&D focus (www.fiercebiotech.com)
- Show HN: Invisitris a Tetris-like game, where the placed pieces become invisible (invisitris.bitechunk.com)
- How BioNTech's "revolutionary" lung cancer vaccine works (bigthink.com)
- BioNTech to Host Second AI Day (investors.biontech.de)
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership (investors.biontech.de)
- BionTech: Lift of Partial Clinical Hold for BNT326/YL202 (investors.biontech.de)
- BioNTech Receives FDA Fast Track Designation for Antibody-Drug Conjugate (investors.biontech.de)
- Bristol Myers makes $11B deal with BioNTech to join the cancer-drug race (www.marketwatch.com)
- BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day (www.instadeep.com)
- BioNTech to Host AI Day as an Edition of Its Innovation Series (investors.biontech.de)
- Dr. Katalin Karikó (2021) (www.glamour.com)
- Promising early data in triple negative breast cancer (www.statnews.com)
- European Patent Office declares Moderna mRNA patent invalid (www.reuters.com)
- Building a global immunotherapy powerhouse translating science into survival (investors.biontech.de)
- Combined flu-Covid vaccine misses a main goal of Phase 3 trial (www.reuters.com)
- Medicine, Technology, Artificial Intelligence, and the End of Cancer (www.nytimes.com)
- Bispecific antibodies that hit key combination of targets in cancer therapy (www.statnews.com)
- Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 (investors.biontech.de)
- Where are all the trillion dollar biotechs? (www.ladanuzhna.xyz)
- Two Biotech CEOs Convicted in Securities Fraud Scheme (www.justice.gov)
- Good drug news – More important things happening in biotechnology and medicine (www.worksinprogress.news)
- China's Biotech Is Cheaper and Faster (www.nytimes.com)